Bardin Hill Management Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Bardin Hill Management Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-334,479	Closed	-$6.31M	–	47
2019 Q3	$6.31M	Buy	+334,479	New	+$3.83M	1.09%	20

Bardin Hill Management Partners's ALDR Position: Q4 2019 in Review

Bardin Hill Management Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 334,479 shares — an estimated $6.31M sold.

Bardin Hill Management Partners first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $6.31M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Bardin Hill Management Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Bardin Hill Management Partners sold 334,479 Alder Biopharmaceuticals shares in Q4 2019, an estimated $6.31M.
Bardin Hill Management Partners first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Bardin Hill Management Partners's Alder Biopharmaceuticals position peaked at $6.31M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Bardin Hill Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.